News

Prior to his retirement from Bristol-Myers Squibb (BMS), Dr Smyth led oncology medical affairs in the US, including the US life-cycle development of paclitaxel (Taxol), carboplatin (Paraplatin) and

The assays have been developed by Nuvera and the University of Texas MD Anderson Cancer Center. The Nuvera test portfolio will also be capable of reporting status of

The Series B financing will be used to accelerate the company’s investment in sales and marketing to meet the demand for i-FACTOR products outside the US as well

Under the agreement, which was announced in November 2008, AstraZeneca receives approximately $220 million for the divestiture. The over-the-counter (OTC) brands, predominantly sold in Sweden, include analgesics Alvedon

China Biologic Products, a plasma-based biopharmaceutical company, has reported a net income of $11.98m, or $0.56 per diluted share, for 2008, an increase of 46.5%, compared to $8.18m,

In addition, the companies have established oncology collaboration for two Bristol-Myers Squibb products – Sprycel (dasatinib) and Ixempra (ixabepilone). Under terms of the agreement Bristol-Myers Squibb will pay

Pursuant to Prescription Drug User Fee Act guidelines, Santarus expects the FDA will complete its review or otherwise respond to the new drug application (NDA) by December 4,

For the full year 2008, the company reported a net loss and comprehensive loss of $25.99 million, or $1.35 per share, compared to a net loss and comprehensive

Enzo Clinical Labs is a regional laboratory serving the greater New York/New Jersey area. Kevin Krenitsky, president of Enzo Clinical Labs, said: “As we continue to develop our